Search results
Insider Selling: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) CEO Sells 9,064 Shares of Stock
ETF DAILY NEWS· 3 days agoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) CEO Leonard S. Schleifer sold 9,064 shares of the company’s stock in a transaction on Tuesday, June 11th. Following ...
Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
Investor's Business Daily· 3 days agoIt's been a decade since the last innovation in treating chronic obstructive pulmonary disease, or...
Investors in Regeneron Pharmaceuticals (NASDAQ:REGN) have seen stellar returns of 220% over the past...
Simply Wall St. via Yahoo Finance· 3 days agoWhen you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and...
Why Regeneron Stock Finally Joined The 1,000-Club
Investor's Business Daily· 4 days agoEnthusiasm is growing for a looming approval in COPD treatment.
Analyst Report: Regeneron Pharmaceuticals, Inc.
Morningstar Research via Yahoo Finance· 2 days agoRegeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several ...
Updates on Aflibercept Biosimilar Approvals and BPCIA Litigation | JD Supra
JD Supra· 7 days agoRegeneron’s regulatory exclusivity for EYLEA expired on May 18, 2024. Two days later, on May 20, 2024, the FDA announced that it has approved Mylan Pharmaceuticals, Inc. and ...
Regeneron (REGN), SNY Win FDA Nod for Kevzara Label Expansion
Zacks via Yahoo Finance· 5 days agoRegeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY announced that the FDA has approved a...
Regeneron, Sanofi Get Expanded FDA OK for Kevzara in Polyarticular Juvenile Idiopathic Arthritis
Morningstar· 5 days agoBy Colin Kellaher Regeneron Pharmaceuticals and Sanofi have won expanded Food and Drug Administration approval of their arthritis drug Kevzara for certain patients with a ...
Regeneron's Dupixent COPD Sales To Reach $20B By 2026, Analyst Sees Larger Addressable Market - ...
Benzinga· 3 days agoAnalyst projects Regeneron's Dupixent to drive COPD sales surge, envisioning $20B market by 2026 on larger addressable market.
Alachua County students take home awards from international science fair
The Gainesville Sun via Yahoo News· 5 days agoThree Alachua County Public Schools students were among nearly 2,000 young scientists from 75...